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1. Introduction 
The scientific community is well aware of the fact that the very presence of internet 
profoundly affects the way research is done. Internet is the major infrastructure through 
which results and data are communicated and shared, computing is parallelized, 
collaborations are started and enlarged, papers are published, and a myriad of other 
transactions are performed, so to involve nearly all aspects of everyday researcher’s life. 
Perhaps surprisingly, scientists paid little attention to the theoretical study of internet 
structure (i.e. topology) and of its dynamical behavior, until quite recently.  
Even more surprisingly, however, when they did it, it quickly emerged some very rarely 
found scientific truth, of such a general kind, to directly reverberate from Internet studies 
into the field of molecular and cellular biology, with very small (if any) changes. 
Consequences manifested immediately, so that, at the turning of the millennium, in a now 
classical Nature paper (Vogelstein B. et al., 2000), Vogelstein, Lane and Levine, the 
discoverers of p53 and of its role as tumor-suppressor, wrote that “The cell, like the Internet, 
appears to be a ‘scale-free network’.” To let the reader fully appreciate this revolution, it is 
useful to recall that in 1999, just one year before the appearance of this particular paper, 
more than 15.000 independent articles have been already published on p53 and its role in 
cancer biology, making this protein one of the most studied topics ever. Yet, after 20 years of 
research, despite the enormous amount of available data, some aspects of p53 biology were 
still missing, and were so crucial to understand why this protein is found mutated in about 
50% of cancer patients, to let its discoverer write “One way to understand the p53 network is 
to compare it to the Internet” (Vogelstein B. et al., 2000). 
What had it happened? To understand this, we must look only two years before. In 1998, 
Zoltan Oltvai, a molecular pathologist, and Lazlo Barabási, a physicist studying Internet 
topology, were both working at the Northeastern University of Chicago. They both were 
Hungarians –actually Barabási was born Romanian, but lived and studied in Hungary - 
have small kids, and were home neighbors; thus it is hardly surprising that, as recalled by 
Barabási himself (Barabási AL, 2002), they usually met for dinner. By that time, Barabási had 
already found out that the Internet structure is a peculiar one: he had collected evidence that 
it is far from random. This was a non trivial result, given the fact that all large networks 
were modeled at the time as random. To understand this point, we have to think of 
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networks made of a huge number of nodes, like human social networks, communication 
networks and alike. To study how they work, i.e. how information spreads through the 
network, or whether the network is sensitive to external attacks, or how to find the best 
pathway from one node to another, it is not possible to perform a direct experiment, given 
the size of the object under study; instead, one has to model the network, then find out a 
proper set of equations, and simulate the behavior of the network varying the equation 
parameters. Since the 60s, the model of choice for large networks was that of Erdős and 
Rényi, which assumes that each node in a network is randomly connected to a fixed, 
average number of other nodes. As Barabási explains (Barabási AL, 2002), Erdős and Rényi 
“acknowledged for the first time that real graphs, from social networks to phone lines, are 
not nice and regular. They are hopelessly complicated. Humbled by their complexity, [they] 
assumed that these networks are random.” In a random network, each node is equivalent to 
every else. Were the real network random, this would have several practical implications. 
For example, removing one server from Internet, was it a random network, would have on 
average the same effect of removing every other node, so that to protect Internet from 
hackers one should only care that, on average, a sufficiently high number of servers is 
shielded, wherever they are. 
However, you could have already guessed that removing 100 servers from the Google 
facilities would have a larger impact on Internet than shutting down 100 servers in rural 
China (at least presently). This is due to the fact that Google machines are Internet hubs, i.e. 
they are continuously connected to an enormous number of other machines, and mediate a 
big amount of Internet data exchange. Barabási and its group were the first to notice the 
presence of hubs in the web (for example, the New York Times web site has an immense 
number of links, whereas an obscure blogger may have none), and recognized that the 
classical network theory of Erdős and Rényi was totally unable to deal with them.  
To see whether this was a peculiarity of Internet or a general finding, they began to map the 
topology of other networks as well. It turned that 1) most real networks are different from 
both regular lattices and random structures and 2) they all exhibit a common underlying 
organization, based on few hubs and many poorly connected nodes. This last point is 
evident if one plots the number of nodes having a defined amount of connections, which is 
called node degree or connectivity, versus the degree itself. One gets a curve (the degree 
distribution), which smoothly descends from a maximum (many nodes with very low 
connectivity) to a minimum (few nodes with very high connectivity); since this curve is 
exponential, the obtained degree distribution obeys a power-law and is said to be scale-free.  
Having already obtained the first evidence for the generality of its finding on network 
structure, Barabási met Oltvai, who, like the majority of the biologists, was very well aware 
of the intricacy of metabolic connections between the molecular constituents of a living cell. 
Indeed, the complicate diagrams on the walls of biochemistry labs represent complex 
networks,  were the nodes are biomolecules of any sort, and the links are biological 
interactions (let us keep this description vague for the moment). The two researchers 
wondered if these biological networks were also scale free as those made by man. By 2002, 
Barabási and Oltvai had published their results obtained from 43 different organisms 
(Ravasz E et al., 2002): the metabolic networks connecting the main metabolites have 
essentially the same large-scale structure of complex, non-biological networks. They are all 
scale-free, with hubs and poorly connected nodes, despite significant differences in the 
particular biochemical pathways included, so that each cell of every examined organism 
resembles a tiny Internet and can be studied in pretty much the same way. 
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With a perfect timing and a great deal of intuition, Vogelstein, Lane and Levine realized 
that, when looking to cancer, p53 is indeed a crucial hub, sitting in the center of a complex 
protein network, and, very much like internet hacking, cellular hijacking by cancer proceeds 
by attacking hubs. This is why, ex post, one finds p53 mutated so many times: touching a 
cellular hub causes a great deal of effects, while mutating less prominent “client” proteins 
passes nearly unnoticed. This is also what brought the three researchers to publish the paper 
which changed p53 science forever. 
Since these early observations, a lot of progresses have been made, to the point that protein 
networks are useful tools in the hands of molecular biologists. The rest of this chapter is 
devoted to a simple introduction to their structure and properties, in a way that purportedly 
simplify mathematical descriptions, keeping an eye on the biological meaning of protein 
networks. 
2. The structure of protein networks: Scale freeness 
Before entering in some details about protein networks, we want to point out some special 
characteristics of this type of networks.  
First of all, one should keep in mind that a protein network is an abstract representation of 
the real world, instead of a physical entity like the Internet infrastructure or a phone line 
web. In particular, while for the latter the links between the nodes are physical (cables in 
both cases), in the former case the links represent only a potential interaction between two 
proteins. With the notable exception of macromolecular complexes, which can be thought of 
as networks of interacting proteins, one would never be able to visualize a protein web 
under a microscope. 
Secondly, with the same exception mentioned before, molecular biologists do usually deal 
with a special type of protein network, one where the nodes represent all of the protein 
copies coded by a single gene, instead of all the individual proteins which are floating 
around in a cell. The protein network we will refer to in the following, thus, is a graph 
which resumes all the known interactions (the links) occurring between the product of every 
gene out of some list (the nodes); in this respect, such a network is more like a map of our 
current knowledge about some specific ensemble of proteins then a representation of a real 
molecular web. 
As a third point, a simplification is usually made, by considering only one type of 
interaction between the proteins composing a given network. The links connecting the 
nodes thus correspond to one out of a number of possible biological interactions, ranging 
from very specific types -such as a network where a link between two proteins represents a 
physical interaction in a molecular complex- to broader concepts -such as a network where a 
link between two proteins occurs if they are found co-expressed in a given condition. 
Correspondingly, different protein networks can be obtained, joining the nodes according to 
different types of interaction: protein-protein interaction networks, transcription networks, 
enzymatic networks, signaling networks, co-expression networks and so on. However, one 
should not consider this simplification as an absolute constraint: software does exist, for 
example, which is able to color the links of a network according to the type of interaction, 
filtering them as wanted.  
We can now start examining an example. Let us consider the human protein-protein 
interaction network, which can be downloaded from the Reactome organization 
institutional site (http://www.reactome.org/download/index.html). At the time when this 
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chapter was written, data were available for more than 5000 proteins, summing up to 120661 
unique physical interactions (including homomeric interactions, i.e. interactions between 
identical proteins). These links do not imply any directed action from a given protein to its 
connected neighbors; thus, as opposite to other types of protein networks, such as 
transcriptional networks, signaling networks and alike, the protein-protein interaction 
network is said to be undirected. The network, on the left of figure 1, is represented as a 
sphere of densely connected dots (the proteins). 
 
 
Fig. 1. Human protein-protein interaction network 
On the right of figure 1, the degree distribution for this network is plotted on a log-log scale; 
as evident by the linearity of the obtained graph (red line), this distribution follows a power 
law, of the form: 
 n ~ k- (1) 
and the network is scale-free. This fact in turn implies that there are few protein hubs, 
connected to most of all other proteins in the network, and a vast majority of proteins able to 
bind only few partners (poorly connected nodes). Hubs will be treated extensively in the 
next paragraph; instead, we will focus here on the properties imparted to a protein network 
by its scale-free nature. 
First of all, let us consider the effects of removing some nodes from a scale-free protein 
network. To this aim, consider the network in figure 2. 
On the left, upper corner, low-degree nodes were selected for removal (and are colored in 
yellow); the resulting network is on the left, lower corner. As evident, the effects are quite 
limited, and all remaining nodes are still fully connected. Consider now the removal of the 
same number of high-degree nodes, as shown in the upper, right corner of figure 2. The 
network falls apart (right, lower corner) and among the remaining nodes, there are 
examples of disconnected proteins, like the ones pointed by red arrows (which are not the 
only ones, if you look carefully). Since high-degree nodes are very rare in a scale free 
network, if compared to low-degree ones, you may have already guessed that protein 
networks are very resistant to random removal of nodes: if we really selected nodes by 
chance, than they will nearly always be peripheral, poorly connected proteins. As a 
consequence, to have even a slight probability of hitting a well-connected protein by 
random selection, we have to remove a disproportionately high number of nodes, or to 
repeat the selection process several times. This property of scale-free networks is called 
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robustness. In the case of protein networks, robustness has some interesting biological 
consequences. First of all, it implies that low-frequency, random events such as protein 
mutations will really affect the cell – which relies for its functioning on several different 
types of proteins and biochemical networks – with an exceedingly low probability. Thus, we 
can say that, even before our immune system takes action against malfunctioning cells, we 
are protected by potentially dangerous random insults – which could give rise to serious 
diseases such as cancer - by the very architecture of the cell protein networks. On the 
opposite side, scale-free determined robustness means that the cell has some true Achille’s 
heels – the few highly connected proteins – which can be exploited by selective attacks. 
Once again, we can refer to Internet for an useful comparison: selective, non random attacks 
to central routers are preferred by hackers, which purportedly aim to take control over the 
attacked networks. At cellular level, viruses can be considered hackers, which divert the 
protein network operations toward an illegitimate scope. Indeed, it has been found by 
several independent groups that viruses selectively target central proteins, causing large 
effects on the host protein network (de Chassey B. et al., 2008; Navratil V. et al., 2011; Zou X. 
et al., 2010). 
 
 
 
Fig. 2. The effects of removing nodes from a protein network: random removal (left) versus 
hub removal (right) 
Beside robustness, scale-free protein networks show another interesting feature. They 
exhibit a small-world behavior: hopping from one node to a neighbor, any node can be 
reached from any other in few steps. The distance L between any couple of nodes, in 
particular, grows roughly proportional to the logarithm of the number of nodes N which are 
included in the network: 
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 L ~ Log(N) (2) 
For protein-protein interaction networks, L grows even slower with N, and the average 
distance between two nodes is so small that they have been defined ultrasmall networks 
(Cohen R & Havlin S. 2003). The small-world property, shared by many complex networks, 
is particular relevant to biology when the considered network is made of proteins which can 
influence the neighbors through the links. This is typically the case of transcriptional 
networks, were two proteins are connected if one influences the expression of the other, 
signaling network, were proteins are coupled through phosphorylation and other post-
translational modifications, and in general holds true for any protein network where the 
activity of one protein affects its connected partners. In these cases,  the small-world 
structure implies that whatever stimulus changes the status or activity of a protein, its 
effects will rapidly propagate to the entire network, since on average only few proteins will 
separate the starting node from every other in the net. This in turn has the consequence that 
a cell, once its protein network has been stimulated at a single, peripheral node, may quickly 
change the status of a large number of proteins in response, so that the original signal 
propagates to a vast number of different proteins, synchronizing their status to the variation 
of the external stimulus. In other words, small-world protein networks, like any other small-
world, display enhanced signal-propagation speed, computational power, and 
synchronizability (Watts DJ & Strogatz SH. 1998). 
In the case of scale-free networks, the observed robustness and the small-world effect are 
mutually connected. In particular, since protein hubs are linked to the vast majority of all 
other nodes, most of the pathways connecting any couple of nodes pass through hubs, so 
that the average distance between any two nodes in the network does not change much if 
nodes are removed randomly: this is a formulation of network robustness equivalent to the 
one we mentioned before. At the same time, the more an hub is prominent, i.e. it is 
connected to an higher amount of protein nodes, the more the distance between any two 
uncoupled nodes will tend to a single hop through the hub. Hubs are thus key features of 
scale-free network, mediating both robustness and small-world properties of protein 
networks; we will dedicate the next paragraph to examine their properties. 
3. The structure of protein networks: Hubs 
Since the early times of protein network studies, the few, always present hubs attracted a lot 
of attention: quite naturally, it was thought that since highly connected proteins have a lot of 
different molecular partners, they should also be implied in the majority of the cellular 
processes. In case of a protein interaction network like the one depicted in figure 2, this 
reasoning goes as follows: proteins found in many different macromolecular complexes, 
represented as hubs in the interaction network, should be either core components of a single 
molecular complex, or elements conserved in many different molecular complexes, which 
works as switches and are used by the cell to coordinate the activation or repression of 
different molecular machineries. As a consequence, any alteration of the hubs of a protein-
protein interaction network is predicted to have large effects on the cell biology. This 
assumption, which has been dubbed as “centrality-lethality rule”, has been extensively 
explored by experimentally knocking-down protein interaction hubs and quantitatively 
assessing the effects in different models (Jeong H. et al., 2011). Going a step further in the 
reasoning, it has been hypothesized that mutations affecting these proteins should be 
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particularly related to the insurgence of diseases. Some experimental validation of this 
prediction has been indeed obtained: Rambaldi and his group (Rambaldi D. et al., 2008) 
provided evidence that virtually all proteins having a degree higher than 80 in the human 
protein-protein interaction network are target of known cancer-related mutations. Similarly, 
Ortutay and Vihinen (Ortutay C. & Vihinen M. et al., 2009), after building an interaction 
network comprising all human proteins involved in immune response, found that the 
network hubs include known disease-causing genes as well as 26 new genes related to 
primary immunodeficiency. In a further example, Chang and colleagues (Chang W. et al., 
2009), found new gastric cancer candidate markers by looking to hubs in a protein-protein 
interaction network build from genes differentially expressed in the patient tissues. 
So far, we looked to hubs in protein-protein interaction networks. However, hubs are a 
common characteristic of any complex web, albeit their biological meaning and relevance 
change according to the particular type of protein network considered. To understand this 
point, let us compare the three different human protein networks reported in figure 3.  
 
 
Fig. 3. A) Co-expression network; B) Biochemical/metabolic network; C) Process specific 
network 
The first network on the left (network A) is obtained by considering all proteins 
differentially expressed in breast cancer patients. Proteins are connected if they are found 
co-expressed in at least 2 different and independent experiments, and the resulting network 
is a co-expression network. The central network (network B) is build by considering all the 
proteins which are linked to the p53 human protein by some known biochemical pathway, 
and is then a biochemical/metabolic network. The last network on the right (network C) is a 
network reporting all those proteins controlled by p53 or controlling it during the unfolding 
of the apoptotic process, and can be seen as a process specific network. You may have already 
noticed that hubs (and scale-freeness) are present in all three webs, despite the fact that the 
network size decreases from left to right. However, the biological relevance of hubs is very 
different in the three network.  
In network A, hubs are cancer markers which are found co-expressed with nearly any other 
cancer protein. Hubs in this network are not granted to be very relevant for the pathogenesis 
of breast cancer: they can be proteins which are deregulated by the inflammation 
accompanying cancer, as well as cytoskeletal proteins altered due to the hyperproliferation 
of cancer cells or other type of very abundant proteins, with no specific role in cancer 
progression and insurgence. While these proteins are indeed dysregulated in breast cancer, 
and thus are useful for diagnosing it, their status of hubs do not privilege them with respect 
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to other, less connected nodes, since their co-occurrence with many partners does not imply 
that their expression level changes more than that of any other node in the network. Indeed, 
the list of hubs of network A includes useful diagnostic proteins, such as ERBB2, ESR1 and 
BCRA1, as well as proteins with little meaning for cancer diagnosis, such as complement 
proteins. Thus, for co-expression networks like the one depicted in figure 3A, being an hub 
is of no particular merit for a protein. 
In network B, since by construction each neighbor of a specific hub is connected to p53 by 
some biochemical chain, hubs are at the crossroad of several cellular pathway involving p53. 
In this respect, hubs of this network are in a prominent position to act as checkpoints for 
controlling the (very redundant) flow of biochemical information from and toward p53, and 
thus we can expect them to be important controllers and mediators of p53 activity. For 
example, we found in network B that the 15 hubs with the highest degree are all different 
subunits of all the three mammalian RNA polymerase, but two, which are important 
transcription factors (TF2A and TF2B); this is hardly surprising, since p53 in the very end 
exerts its prominent and multiple actions regulating the transcriptional process, so that all 
p53 pathways converge into the regulation of the RNA polymerase machinery. By 
considering hubs with a lower degree, we find the mitosis controlling kinase NEK-2, the 
nuclear cap-binding protein 1 and 2, and several other proteins which have prominent roles 
in regulating the cellular status. As a general rule, although there are exceptions, the lower is 
the degree, the more specific is the position of the protein in the p53 network (or the lesser is 
known about it). For example, among the proteins having k=1, we find the liprin alpha 4, a 
protein which binds to the intracellular membrane-distal phosphatase domain of tyrosine 
phosphatase LAR, and appears to localize LAR for regulating the disassembly of focal 
adhesion and orchestrating cell-matrix interactions; or E2F-3, a transcription factor which 
binds specifically to the protein RB1 , in a cell-cycle dependent manner; or MDB4, the 
Methyl-CpG-binding domain protein 4, which is a mismatch-specific DNA N-glycosylase 
involved in DNA repair, specific for G:T mismatches within CpG sites. Thus, for 
biochemical/metabolic networks like the one depicted in figure 3B, hubs are checkpoints for 
most of the pathways considered in building the network (in the presented case, p53-related 
pathways), acting as crucial mediators of biological activity and behaving like switches for 
several biochemical pathways. On the opposite site, if interested to specific, less studied 
biochemical players, one should concentrate on low-degree nodes of the network, a group 
which is enriched in proteins involved in few, specific metabolic modules. 
In network C, starting from p53, nodes are attached if they co-occur in at least one 
biochemical pathway and are involved in apoptosis. The fact that two proteins co-occur in 
more than one pathway is represented by multiple links. This network can be considered as 
extracted from network B, by filtering out those proteins not involved in apoptosis. As for 
network B, hubs of this network are to be considered prominent biochemical regulators; 
however, since we are restricted to a single, specific biological process, there is no special 
role for low-degree proteins, which are simply peripheral players in a specific apoptotic 
pathway, among the many redundant possibilities. Hubs are thus the only targets for the 
analysis of network C: they are important mediators of p53-related apoptosis, controlling 
most of the network, and their knocking out can be expected to perturb largely the apoptotic 
control of the cell. As a matter of fact, ordering by degree the nodes of this network, after 
p53, which is trivially an hub, we find MDM2, possibly the most important regulator of p53 
mediated apoptosis, and the apoptosis-stimulating protein of p53 ASPP2, which influences 
the apoptotic response of cells without affecting p53-induced cell cycle arrest. On the 
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opposite side, we find cdc42, an important cellular protein, which nonetheless mediates only 
one of the apoptotic pathways controlled by p53 (Thomas A. et al., 2000). Thus, for networks 
like that depicted in figure 3C, hubs may be considered the most relevant proteins to be 
found involved in the selected biological process, and they can be safely assumed as targets 
for further analysis. 
After the preceding discussion, it should be clear at this point that protein hubs are 
extremely variable in their relevance, and that before considering the degree of a node as a 
topological guide to prioritize protein lists, one must carefully select the type of network to 
be used, i.e. the rule to generate links between nodes. However, even having the best 
network may be not enough. To understand why, let us first make a general consideration 
and then go on with an example. 
 
 
Fig. 4. Sampling bias in biological networks 
As shown in figure 4, we must face a sampling problem. “Sampling”, in this context, means 
to accumulate knowledge on a specific node or part of the network, useful to define its 
connectivity. In facts, whatever biological network we are exploring, we are only getting an 
incomplete representation of the real thing, one which was produced by a finite number of 
experiments interrogating a biological entity. If sampling of the real network (sitting on the 
lower plane in figure 4) is non-random, i.e. it is concentrated around some “hot” protein 
(represented in red), then we get a skewed representation (sitting on the upper plane in 
figure 4) where nodes originally having the same degree are represented as very different in 
the reconstructed network. Besides being biased, the representation we have can also be 
error-prone. For example, in figure 4 many links are missing on the upper plane as 
compared to the lower one (negative error); the opposite situation, were extra links are 
erroneously added to the representation – for example due to non-specific binding in 
protein interaction experiments – is also common. Both errors and biases obviously affect 
the definition of hubs in a network. However, while simple tests exist to check whether an 
identified hub is a genuine one in an error-prone web (Vallabhajosyula RR. et al., 2009), bias 
may have subtler effects, much more difficult to deal with. To see this last point, let us 
consider a further example.  
On the left of figure 5, there is a co-expression network which includes all proteins studied 
in breast cancer. Two proteins are connected if, by any experimental method, they were 
found to be co-expressed in a breast cancer human sample, whatever the stage or the 
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provenance of the sample. Proteins which are known targets for drug currently used to treat 
breast cancer or under development are highlighted in red. On the right of the same figure, 
there is a box-plot which shows the degree distribution for nodes which have been never 
entered the drug development process (first box on the left), are in preclinical development 
(second box), are in clinical development phases (phase I, II and III corresponding to the 
third, fourth and fifth box respectively) and are already on the market (last box on the right). 
A clear trend may be seen, with the degree regularly increasing as the clinical development 
of a target proceeds. Is this a genuine trend to be used for drug target identification, i.e. is it 
true that the more a protein is an hub, the better is to target it from a pharmacological 
perspective? Quite the opposite. If we consider the same network in a temporal perspective, 
we will see why. Have a look at figure 6. For the sake of simplicity, we will focus on three 
exemplary pharmaceutical targets in breast cancer (the vascular endothelial growth factor 
VEGF, the tymidilate synthase TYMS and the clusterin CLU). 
 
 
Fig. 5. Degree distribution for pharmacological targets in a breast cancer co-expression 
network 
We want to study their position as hub during time, to see whether it is constant or changes, as 
new experiments are performed and new network nodes are added. Since the network grows 
in time, instead of the degree we will consider the ratio between the degree and the total 
number of nodes; this is the fraction of network nodes connected to the considered protein, 
and we will refer to this quantity as to “net occupancy”. You may have already noticed that 
this quantity varies in an unpredictable manner. Something connected to about 6.5% of all 
network nodes in 1993 (TYMS), a true hub for the network, became connected to less than 1% 
in 2002, to go back to about 3% in 2009. VEGF, which was an important hub in 2009, was 
barely connected to the network before 1997, and was certainly not an hub by that time. From 
the graph, we can notice three temporal points associated to an abrupt trend change for all the 
selected proteins: 2002 for TYMS, 1997 for VEGF and 2005 for CLU. What happened at the 
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time? In 2002, pemetrexed, a drug targeting TYMS, was introduced for breast cancer therapy; 
in 1997, the antiangiogenic therapy was hypothesized as an option to treat breast cancer; in 
2002, the experimental drug OTX-111, targeting CLU, was shifted to prostate cancer, due to 
mixed results in breast cancer trials. We can thus directly observe that, in the selected cases, the 
industrial interest immediately precedes a topological change of a protein in the network, 
promoting to hubs those proteins which are under industrial development, and downsizing 
those proteins which were not up to the standard in clinical trials. Such kind of an effect may 
also be caused by interests different from the industrial ones. For example, it is probable that 
strong academic groups tend to produce a lot of data on their “pet” proteins; moreover, most 
studied proteins tend understandably to be of human origin, well soluble, stable and easily 
detected. Large scale “unbiased” experiments, such those using microarrays, two-yeast hybrid 
or proteomic techniques, produce data which are also biased toward detectable proteins 
(Ivanic J. et al., 2009), and are still very often affected by the interest of the experimenter (think 
to the study of knock-out models). Some possible solutions which have the potential to 
mitigate biases as well as errors in reconstructing protein networks have been recently 
proposed. These approaches make use of network alignment between different organisms 
(Tan CS. Et al., 2009). In particular, evidence has been recently produced demonstrating that 
even though the present protein network data are strongly biased by the experimental 
methods used to produce them, they still exhibit species–specific similarity and reproducibility 
(Fernandes LP. Et al., 2010). While intra-species conservation approaches tend to contribute 
“core” networks, i.e. networks made of conserved proteins and conserved topologies which do 
not account for inter-species variability, they have the indubitable advantage to average biases 
(because the networks used for the alignment come from different scientific communities, and 
are less vexed by pharmaceutical industry interests) and errors (because more large scale 
experiments are taken into accounts). Moreover, hubs conserved among different species are 
likely to be very relevant for the basic biology of the cell, as shown by the fact that they tend to 
be duplicated so to increase the mutational robustness of the corresponding biological network 
(Kafri R. et al., 2008) 
 
 
Fig. 6. VEGF, TYMS, and CLU network occupancy 
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We want to conclude this paragraph by the following message: when properly taking into 
account biases and errors, the topological prominence of hubs is indeed informative and 
useful for protein/gene prioritization; however, the real biological meaning of “hubbiness” 
is strictly dependent on the linking rule applied for building a specific network, as shown in 
this paragraph for co-expression networks, biochemical/metabolic networks and process 
specific networks. 
4. The structure of protein networks: Neighborhoods 
In a graph, the neighbors of a given node consist in all those other nodes that are connected 
to it up to a certain distance. Distance in this context is intended as the minimal number of 
steps connecting the source node to any other. In other words, for a particular protein x in a 
network (which we will call the seed), we define the neighborhood of x, N(x), to be the 
subgraph of the network whose vertex set consists of all of x’s interaction neighbors and the 
edges between them, up to a preselected distance D.  
According to the type of graph, neighborhoods can be used to derive useful biological 
information.  
We will try to illustrate this by showing how: 
1. in a network, the biological roles of the neighbors can be used to infer the unknown 
functions of a seed;  
2. in protein-protein interaction networks, a group of highly interconnected neighbors 
sharing a given biological function likely coincides with a macromolecolar complex or 
part of it. 
As for the first example, it is useful to remember that traditionally the function of a protein 
is inferred from its sequence and/or structure by homology modeling. Unsurprisingly, this 
approach performs poorly for those proteins which have unusual sequences and unknown 
structures. In this particular circumstances, an analysis of the biological functions of the 
network neighbors of the protein can be decisive. In particular, it has been proved that in 
protein networks the probability that a certain biological function is shared between two 
proteins is higher if the 2 considered proteins are proximal neighbors, and then decreases as 
the distance D increases (Shamir R. et al., 2007). This is true in many different network 
types, such as protein-protein interaction networks, metabolic/biochemical protein 
networks, genetic interaction networks etc. Moreover, if a given protein with an unknown 
function is at short distance (usually D=1) from several proteins sharing a given function, 
the probability that it too shares that particular function is obviously even higher. On this 
basis, a neighborhood-guided labeling strategy is possible to assign biological functions to 
virtually any protein in a network, providing that at least a fraction of the nodes in its 
neighborhood has a known biological role. The process is exemplified in figure 7, were 
functional annotation is symbolized by node coloring.  
As can be intuitively understood by looking at figure 7, the functional annotation of a given 
node is guided by several factors, including  distance and number of neighbors with a given 
biological function, their own connectivity and their heterogeneity (which led to the lack of 
propagation for the red and the blue colors in the example). Mathematical modeling of the 
labeling procedure basically consists in weighting all these factors in a single probability 
function, so to obtain a score for the assignment of a given biological role to all the network 
nodes. While the details of the proposed methods are out of the scope of this introductory 
text, we would like to stress here that the procedure depends always on the local topology, 
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which affects the label propagation by determining the number of neighbors a given node 
communicate with, and on the type of network considered, which limits the distance and 
the direction of propagation of a label along the edges. 
 
 
Fig. 7. Functional annotation of a given node 
As for the second example, we will refer to a recent work of Fox et al. (Fox AD et al.,  2011) 
on protein-protein interaction networks. Consider in particular the two alternative 
situations illustrated in figure 8. 
In A, the neighborhood for D=1 of the selected seed (shown in blue) is made of two groups 
of nodes, which are not directly connected; on the opposite, in B the neighborhood is highly 
interconnected in a single cluster. 
 
 
Fig. 8. A) Two disconnected neighborhood; B) Highly interconnected neighborhood 
As reported by the authors, the structure observed in A suggests the possibility that the two 
groups of neighbors might be active under different conditions, as opposite to B. Indeed, it 
was found that single-component neighborhoods like the one represented in B are enriched 
in protein sharing similar functions and participating to molecular complexes, and are thus 
more likely to represent a single, defined protein complex, while multiple-components 
neighborhoods like the one represented in A tend to represent different molecular 
complexes, sharing a single component. Interestingly, we found that this concept can be 
extended beside protein-protein interaction networks. Let us consider, for example, all those 
proteins, which are reported as changed in expression by at least two different papers on 
Parkinson’s Disease. We will consider two proteins connected, if they co-occur at least 2 
Starting network Expandedannotation
A B
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times, i.e. if they are reported together by at least two papers. The obtained co-expression 
network is shown in figure 9A. 
 
 
Fig. 9. A) Parkinson’s Disease co-expression network; B) A clique from the same network 
(red nodes have many connections outside the clique).  
On the right, in figure 9B, a neighborhood of 14 proteins is extracted from the network, 
which are all fully interconnected (meaning that each protein is connected to any other). 
Among these 14 proteins, the red ones are those which have at least as many bonds outside 
the neighborhood as they have inside it (i.e. at least 13 bonds outside the network). These 14 
proteins are arranged in a way similar to that exemplified in figure 8B: a single cluster of 
highly connected nodes. Much in the same way predicted for protein-protein interaction 
networks, the cluster is enriched in proteins sharing some functional aspect: in particular, it 
turns out that 13 out of the 14 components are found in inclusion bodies, a hallmark of 
neurodegeneration in Parkinson’s Disease. Intriguingly, in a sense they represent once again 
a macromolecular complex – albeit a non-specific one, being a structurally random 
aggregate, which may vary in its particular composition from case to case. Thus, while the 
starting network is a co-expression network, where edges do not represent physical 
interactions among proteins, also in this case proteins in well connected neighborhoods tend 
to share biological functions and to be involved in the formation of complexes. 
5. The structure of protein networks: Graphlet degree signatures 
Until now, we have examined pretty simple topological features of the nodes in a protein 
network. Recently, however, more complex metrics have been introduced, which have 
several advantages over the older ones. In particular, many of these sophisticated 
parameters are useful because they recapitulate a larger amount of information with respect 
to simpler ones. One of such parameter is the “graphlet degree signature” of a node, first 
introduced by Milenković T. & Przulj N. (2008). To understand what is it, let us consider 
figure 10. 
Imagine that we want to study the local topology around the two colored nodes shown in 
figure 10A. A possible way would be to count all the graphlets of a certain type which pass 
through the nodes. Graphlets are small connected network subgraphs with a pre-
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determined number of nodes. In figure 10B, we reported all the possible graphlets with 2 
nodes and 3 nodes, with the designation G0, G1 and G2 originally introduced by Pržulj. As 
evident by figure 10C , node 1 is touched by 3, 3 and 1 G0, G1 and G2 graphlets respectively. 
Node 2 is touched by 5, 5 and 2 G0, G1 and G2 graphlets respectively. You can check the 
number of G0 and G1 graphlets on the left part of figure 10C, and the number of G2 graphlets 
(triangles) on the right; these numbers are called G0, G1 and G2 graphlet degree of a node. 
Thus, with respect to two- and three nodes graphlets, it is possible to define an ordered 
vector of the type <g0, g1, g2>, which will describe for each node how many graphlets of any 
possible type actually pass through the node. For node 1 and node 2, this vector assumes the 
values of <3,3,1> and <5,5,2> respectively. The vector obtained considering all the 29 
possible graphlets having from 2 to 5 nodes has been originally dubbed “graphlet degree 
signature” or simply “signature” of a node. 
 
 
 
 
 
 
 
 
Fig. 10. A) Two nodes with a distinct topology; B) All the possible connection arrangement 
(graphlets) for groups of 2 or 3 nodes; C) Left, prevalence of G0 and G1 graphlets passing by 
nodes 1 and 2; Right, prevalence of G2 graphlets passing by nodes 1 and 2. 
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Before going further, it is important to note the following: 
1. the G0 degree is equivalent to the node degree we saw in the preceding paragraphs; in 
this respect, the graphlet degree signature can be seen as a generalization of the node 
degree, which is not limited to the count of only a single type of graphlet; 
2. By considering the type and number of graphlet connected to a node, the graphlet 
degree signature captures in a single metric both the degree of the node, the 
neighborhood abundance and its topology, recapitulating in a single measure the 
complementary aspects we introduced in the previous paragraphs. 
Once defined in the way we have seen, the graphlet degree signature can be used to cluster 
all the nodes of a network according to their similarity. We will not enter into the details of 
the method, which is fully described elsewhere (Milenković T. & Przulj N. 2008); to our 
purposes, it is enough to understand that nodes with a graphlet degree signature similar 
above a certain threshold (which implies a similar centrality and a topologically equivalent 
neighborhood) can be grouped together. The resulting groups, however, may contain nodes 
which are quite far in the original network, so that nodes in the same cluster are in general 
scattered all over the network. Mostly relevant to the biologist, it has been shown how these 
clusters contain proteins of similar biological role and functioning (Milenković T. & Przulj 
N. 2008). This means that, at least in principle, if one selects a node with known biological 
features, it is possible to calculate its graphlet degree signature, search for nodes with a 
similar signature and transpose the biological features to what has been found, without 
considering the distance of the newly identified nodes from the starting point, as opposite to 
what we have seen in the previous paragraph. 
6. A brief review of successful applications 
We will see at this point how the topological analysis of biological networks has been 
already applied to achieve interesting results. Due to the limited space, we will restrict 
ourselves to few examples; however, the literature describing successful applications of 
network analysis in biology is growing at exponential rate, as evident by comparing the 
papers produced yearly and indexed by Pubmed for “network biology”in 2000 (372) to the 
corresponding figure for 2010 (2324). 
A first, obvious application of topological network analysis consists in illuminating new 
aspects of the cell biology, which are evident only when looking to the full puzzle 
represented by a molecular net, instead then to the single pieces of it. The instruments used 
for such an analysis are many; however, even the simplest topological descriptors we have 
introduced in this chapter, such as the cliques, may be very useful. 
To illustrate this point, let us refer initially to the classic work of Spirin and Mirny on the 
yeast protein-protein interaction network (Spirin V. & Mirny LA. 2003). These two authors 
were the first to describe the presence of densely connected modules in protein-protein 
interaction network, i.e. neighborhoods whose internal connectivity is very high compared 
to the average network connectivity. As we already know, in extreme cases – i.e. in case all 
the neighborood’s components are fully connected – these protein groups are cliques. As 
discovered by the aforementioned authors, cliques and very connected neighborhoods 
represent molecular complexes and/or functional modules. Thanks to this fact, the authors 
were able to identify a full wealth of new functional modules, including several previously 
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unknown molecular machineries, such as an eight-member module of cyclin-dependent 
kinases, cyclins and their inhibitors regulating the cell cycle, a six-member module of 
proteins involved in bud emergence and polarity establishment and a six-member module 
of CDCs, septins, and Ser/Thr protein kinases involved in mitotic control. From their 
starting seminal work, which for the first time shifted the network analysis from single node 
centrality to community of nodes, a deluge of research followed. This trend culminated in 
several complex applications of clique analysis, such as a recent work which nicely 
illustrated how the mitotic spindle functioning is regulated by a cascade of events which 
involves cliques (i.e. molecular complexes) instead of single proteins (Chen TC. Et al., 2009). 
With regard to more complex topological parameters, such as the graphlet degree signature 
introduced in the previous paragraph, there are obviously fewer examples, given the fact 
that they have been introduced much later. However, being refined instruments, the results 
obtained by their systematic application are somehow superior in generality, and uncover 
the real potency of the topological approach in molecular network analysis. To understand 
this, is sufficient to read a recent paper by Milenkovic T. et al., 2010. The authors describe 
how in a human protein-protein interaction network oncogenes do have a very similar 
graphlet degree signature, which is different from that of genes unrelated to cancer, at a 
point that they are able to use this signature to identify new oncogenes. If this finding will 
be confirmed by others, we will be forced to admit that the detailed topology around a node 
in a global protein-protein interaction map is important in determining the function of the 
corresponding protein at least at the same level as its sequence and three-dimensional 
structure – a somehow unexpected result, given the fact that protein-protein interaction 
networks are only a very abstract map of all the interactions which have been observed, 
without spatial and temporal resolution, and do not corresponds to any physical entity. 
However, we want to conclude this paragraph by stressing the fact that, albeit this and 
similar fundamental problems rest to be solved, and are matter of current and future 
research in the field, we are seeing already the first applications of network analysis in 
human therapy. In particular, although network science is still in its infancy, it is currently 
shifting from a better understanding of why a given drug works or not to the identification 
of new therapeutic interventions. As an example, consider the case of multi-drug therapy, 
which is a very active field of research and experimental work, due to its high potential in 
overcoming several obstacle to the effective pharmacological treatment of different 
conditions. As opposed to the classical “magic bullet” pharmacological paradigm, aiming to 
the ultra-specific targeting of a single protein, a new kind of approach to the design of a 
therapy is emerging, which relies on simultaneously targeting several molecular processes. 
The topological analysis of the molecular network underlying a specific disease is the only 
way to rational implement such an approach, allowing the quest for modulators acting on 
different network areas, so to attack different cellular pathways. This way to proceed was 
recently validated by some groups, which could identify the right combination of drugs to 
be used in a number of oncological conditions, such as incurable pancreatic adenocarcinoma 
(Azmi AS. Et al., 2010), as well as head and neck chemoresistant cancer (Ratushny V. et al., 
2009). 
From the point of view of the network topology, the approaches described in these papers 
can be seen as the targeting of control hubs within neighborhoods with quite distinct 
compositions and cellular functions (i.e. separated neighborhoods enriched in proteins with 
different functional annotation), a practical strategy which relies on the concepts discussed 
previously in this chapter and which wait to be extended to several other cases. 
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7. Conclusion: A concept-map for the analysis of network topology 
Having listed some few examples, we would like to recall to the attention of the reader those 
elements which allow a successful analysis: a proper selection of the data set to start with, a 
correct identification of the rules used to build the network (i.e. the type of network to be 
analyzed), few general assumptions on the relationships between the topology and the 
biological properties of the proteins to be found, and a correctly chosen null-hypothesis for 
the minimization of false positives (which, if possible, should also take into account bias and 
errors). 
Let us discuss briefly the first point, i.e. the selection of a proper data set to derive the nodes 
of the network. This step is crucially influenced by the scope of the network. For example, if 
the aim is to find potential drug targets for a given condition, a literature-derived dataset, 
including all the proteins known to be related to a certain disease – irrespectively of the type 
of relation they have with the studied condition - might be useful. A protein expression data 
set, containing data on differential protein expression, would be equally useful. On the 
contrary, taking into account a complete protein-protein interaction data set may be both 
misleading – given the fact that there is no guarantee that the proteins contained in it are 
expressed in the selected condition – and useless, because this type of database lacks 
information on those proteins which have strong activity and expression in the selected 
condition, but do not have any identified molecular partner. 
As for the second point, usually people select the type of network (and thus the node linking 
rule) they want to build at the very first step – i.e., they use protein interaction databases to 
build protein-protein interaction networks, expression databases for co-expression networks 
and so on. However, there are certain cases were this passage is not automatic. For example, 
if the data source for the node list is the scientific literature, instead of building a literature 
co-occurrence network one can derive the linking rule from a different source, like a 
microarray experiment database. By combining a literature-derived list of nodes with 
microarray information for linking them, one would obtain a network, whose nodes are 
selected on the basis of a specific scientific topic, and are bound by co-expression, without 
the need to perform  an actual experiment in the condition of interest. 
As for the third point, it is true that, in general, the topology of a node is correlated to the 
relevance of the role that the corresponding protein plays in the particular condition the 
network refers to. However, one has to recall that: 
1. The meaning of “topologically relevant proteins” varies with the type of network – for 
example, hubs in co-expression networks are usually housekeeping proteins, while in 
protein-protein interaction networks they may be core constituent of molecular 
complexes; 
2. the specific meaning varies also with the network dimension – so that in a network 
including the full yeast proteome, topologically prominent proteins are heterogeneous 
in function, while in a network made of proteins involved in apoptosis the hubs are key 
apoptosis regulators; 
3. obviously protein prioritization is affected by the particular topological quantity one is 
measuring –a protein may be an hub, yet may have no clique including it; 
4. the relevance of a protein for the cell may be in gross contrast with what is perceived as 
relevant by the investigator – housekeeping proteins are very relevant to the 
functioning of the cell, but not so to someone wanting to find new drug targets. 
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Finally, coming to the forth point, we want to stress here that control models to be used for 
underpinning significant topological properties should vary, depending on the topological 
quantity under study. Thus, to get a control network for testing the relevance of some 
topological characteristic of a certain group of node, one may compare the results obtained 
on the actual network with those obtained in: 
a. a random network, i.e. a network made of the same number of nodes and edges, with 
fully random connection between the nodes- this is enough to test for the global 
distribution of topological quantities, such as the degree distribution or the existence of 
statistically relevant neighborhoods; 
b. a degree-preserving random network, i.e. a network made of the same number of nodes 
and edges, with the degree of each node preserved, but a completely different wiring – 
this is the proper control, when one want to test the association between some 
topological parameter and a specific biological attribute, which depends on the 
particular nodes considered; 
c. a set of random network (degree preserving type or not) – this is the proper control, 
when one want to test the probability of the emergence of the observed topology in a 
network 
 
 
 
 
Fig. 11. Concept map for network topology analysis 
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After these considerations, we will conclude this chapter by outlining a general concept-
map, reported in figure 11,  which we feel can be useful in analyzing the topology of protein 
networks. This map should be regarded as a contribution to avoid common 
misinterpretations of the meaning of topological parameters in different contexts, not as an 
all-inclusive description of the possible applications and types of protein networks. 
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